462 related articles for article (PubMed ID: 32627126)
1. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
Mondal R; Lahiri D; Deb S; Bandyopadhyay D; Shome G; Sarkar S; Paria SR; Thakurta TG; Singla P; Biswas SC
J Thromb Thrombolysis; 2020 Oct; 50(3):567-579. PubMed ID: 32627126
[TBL] [Abstract][Full Text] [Related]
2. COVID-19-associated vasculitis and vasculopathy.
Becker RC
J Thromb Thrombolysis; 2020 Oct; 50(3):499-511. PubMed ID: 32700024
[TBL] [Abstract][Full Text] [Related]
3. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.
Lahiri D; Mondal R; Deb S; Bandyopadhyay D; Shome G; Sarkar S; Biswas SC
Diabetes Metab Syndr; 2020; 14(5):1053-1060. PubMed ID: 32640417
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 pandemic, coronaviruses, and diabetes mellitus.
Muniyappa R; Gubbi S
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E736-E741. PubMed ID: 32228322
[TBL] [Abstract][Full Text] [Related]
6. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
Yao Z; Zheng Z; Wu K; Junhua Z
Aging (Albany NY); 2020 May; 12(9):7639-7651. PubMed ID: 32364527
[TBL] [Abstract][Full Text] [Related]
7. Viral and host factors related to the clinical outcome of COVID-19.
Zhang X; Tan Y; Ling Y; Lu G; Liu F; Yi Z; Jia X; Wu M; Shi B; Xu S; Chen J; Wang W; Chen B; Jiang L; Yu S; Lu J; Wang J; Xu M; Yuan Z; Zhang Q; Zhang X; Zhao G; Wang S; Chen S; Lu H
Nature; 2020 Jul; 583(7816):437-440. PubMed ID: 32434211
[TBL] [Abstract][Full Text] [Related]
8. The trinity of COVID-19: immunity, inflammation and intervention.
Tay MZ; Poh CM; Rénia L; MacAry PA; Ng LFP
Nat Rev Immunol; 2020 Jun; 20(6):363-374. PubMed ID: 32346093
[TBL] [Abstract][Full Text] [Related]
9. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
10. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
Ahlawat S; Asha ; Sharma KK
Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
[TBL] [Abstract][Full Text] [Related]
11. An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic.
Jamwal S; Gautam A; Elsworth J; Kumar M; Chawla R; Kumar P
Life Sci; 2020 Sep; 257():118105. PubMed ID: 32687917
[TBL] [Abstract][Full Text] [Related]
12. Early Insights into Immune Responses during COVID-19.
St John AL; Rathore APS
J Immunol; 2020 Aug; 205(3):555-564. PubMed ID: 32513850
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course.
Bansal R; Gubbi S; Muniyappa R
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32603424
[TBL] [Abstract][Full Text] [Related]
14. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity.
Ovsyannikova IG; Haralambieva IH; Crooke SN; Poland GA; Kennedy RB
Immunol Rev; 2020 Jul; 296(1):205-219. PubMed ID: 32658335
[TBL] [Abstract][Full Text] [Related]
15. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
Li YC; Bai WZ; Hashikawa T
J Med Virol; 2020 Jun; 92(6):552-555. PubMed ID: 32104915
[TBL] [Abstract][Full Text] [Related]
16. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
17. Extra-respiratory manifestations of COVID-19.
Lai CC; Ko WC; Lee PI; Jean SS; Hsueh PR
Int J Antimicrob Agents; 2020 Aug; 56(2):106024. PubMed ID: 32450197
[TBL] [Abstract][Full Text] [Related]
18. Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection.
Labò N; Ohnuki H; Tosato G
Cells; 2020 Jun; 9(7):. PubMed ID: 32629875
[TBL] [Abstract][Full Text] [Related]
19. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS
Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933
[TBL] [Abstract][Full Text] [Related]
20. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
Asrani P; Hasan GM; Sohal SS; Hassan MI
OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]